# Effects of Adalimumab on Mucosal Healing in Subjects With Crohn's Disease Involving the Colon

> **NCT00348283** · PHASE3 · COMPLETED · sponsor: **Abbott** · enrollment: 135 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **BIOLOGICAL:** adalimumab
- **BIOLOGICAL:** placebo
- **BIOLOGICAL:** adalimumab

## Key facts

- **NCT ID:** NCT00348283
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2008-09
- **Final completion:** —
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2011-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00348283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00348283, "Effects of Adalimumab on Mucosal Healing in Subjects With Crohn's Disease Involving the Colon". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00348283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*